US still expects to meet vaccine target despite Johnson & Johnson issues – New York Post2 min read

https://nypost.com/2021/04/12/us-expects-to-hit-vaccine-target-despite-johnson-johnson-issues/

” You can expect even without additional doses from Johnson & & Johnson for us to be somewhere because community,” Slavitt said at a coronavirus press instruction.

” You do the math. There is lots of supply to continue to immunize Americans at 3 million per day, and then some. Thats not to point out the truth that there are numerous dosages that have already been distributed into states.”

Andy Slavitt, a senior adviser to President Bidens coronavirus action group, stated that the drugmaker is still on track to deliver 24 million dosages in April.

The manufacturing plant wasnt authorized to supply dosages yet anyhow and is currently waiting on approval from US regulators.

The United States still expects to fulfill its target for delivering COVID-19 vaccines despite Johnson & & Johnson battling with production, a White House senior assistant said Monday.

Andy Slavitt, senior advisor to the White House COVID-19 Response Team, speaks throughout a White House briefing on the Biden administrations action to the COVID-19 pandemicAP

The Centers for Disease Control and Prevention had actually stated that shipment of the vaccine were to drop this week by more than 80 percent, though the cause is uncertain.

Some state officials blamed an agreement plant in Baltimore, where at least 15 million shots were polluted when employees reportedly blended active ingredients with another shot.

Adam Dentinger, a UPS delivery driver, rolls a freight cart of vaccine ancillary kits at Louisville Metro Health and Wellness headquarters in LouisvilleGetty Images

” And they stay positive that theyre going to have the ability to provide at or near 24 million this month and over or close to 100 million by May.”

” We are pleased by the truth that Johnson and Johnson in the meantime has taken control of the plant, has actually gotten rid of the confounding aspect of another vaccine being produced there,” Slavitt stated.

Leave a Reply

Your email address will not be published. Required fields are marked *